|
Clausena
|
B01.650.940.800.575.912.250.875.216 |
|
|
Cytidine Diphosphate Choline
|
D02.092.877.883.333.130 |
|
|
Mars
|
G01.060.075.730.700.625 |
|
|
Core Binding Factor Alpha 1 Subunit
|
D12.776.930.155.200.100 |
|
|
Cerebral Blood Volume
|
G09.188.130.185 |
|
|
Vincamine
|
D03.633.100.473.402.681.827.750 |
|
|
bcl-X Protein
|
D051020 |
[Bcl-XL is an anti-apoptotic protein that is the long isoform of Bcl-X protein. Bcl-XL localizes to the outer mitochondrial membrane and is overexpressed in most human NEOPLASMS. It has also been implicated in ISCHEMIC HEART DISEASE.
, A pro-apoptotic protein that is the short isoform of Bcl-X protein. Bcl-XS lacks the BH1 and BH2 domains of BCL-XL PROTEIN and it inhibits the ANTI-APOPTOTIC PROTEINS of the bcl-2 protein family.
, A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS and is a regulatory subunit for PROTEIN PHOSPHATASE 1. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL.
] |
|
BH3 Interacting Domain Death Agonist Protein
|
D051023 |
[A C-terminal fragment of Bid protein that is produced by caspase cleavage. tBID is the active from of the protein and it redistributes from the CYTOSOL to MITOCHONDRIA to promote release of CYTOCHROME C.
, A member of the Bcl-2 protein family that reversibly binds MEMBRANES. It is a pro-apoptotic protein that is activated by caspase cleavage.
] |
|
Inhibitor of Apoptosis Proteins
|
D12.644.360.075.437 |
|
|
bcl-Associated Death Protein
|
D051025 |
[A pro-apoptotic protein and member of the Bcl-2 protein family that is regulated by PHOSPHORYLATION. Unphosphorylated Bad protein inhibits the activity of BCL-XL PROTEIN.
] |
|
CD59 Antigens
|
D12.776.543.550.418.140 |
|
|
Phosphoribosylglycinamide Formyltransferase
|
D051026 |
[An enzyme that catalyzes the transfer of a formyl group from N10-formyltetrahydrofolate to N1-(5-phospho-D-ribosyl)glycinamide to yield N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide and tetrahydrofolate. It plays a role in the de novo purine biosynthetic pathway.
] |
|
Phosphoribosylaminoimidazolecarboxamide Formyltransferase
|
D051027 |
[An enzyme that catalyzes the conversion of aminoimidazole-4-carboxamide ribonucleotide to 5-formyl-aminoimidazole-4-carboxamide ribonucleotide in the purine de novo synthesis pathway. It requires the cofactor N(10)-FORMYLTETRAHYDROFOLATE as the formyl donor.
] |
|
bcl-2-Associated X Protein
|
D051028 |
[A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein.
] |
|
RNA, Protozoan
|
D13.444.735.650 |
|
|
Tamarindus
|
B01.650.940.800.575.912.250.401.875 |
|
|
alpha-MSH
|
D06.472.699.631.525.600.179 |
|
|
Regression Analysis
|
N06.850.520.830.750 |
|
|
Busulfan
|
D002066 |
[An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.
] |
|
Buserelin
|
D002064 |
[A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications.
] |
